CAMPTO conc perf 300 mg/15ml Cytosafe 15 ml

7680534700497 CH-53470 L01CE02 07.16.1.
CAMPTO conc perf 300 mg/15ml Cytosafe 15 ml
CAMPTO conc perf 300 mg/15ml Cytosafe 15 ml
1 / 2
google

Details

Product number
5347003
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml.

Articles (1)

Campto 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
12/09/2024
Professional SmPC
Français
12/09/2024
Professional SmPC
Italien
12/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
675.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 328.05
Specialties list
Yes
Generic
No
SL addition date: 01/05/2008

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
53470
Drug name
Campto, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01CE02
Authorization status
Z
Dispensation category
A
First authorization
08/05/1998
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
CAMPTO conc perf 300 mg/15ml Cytosafe 15 ml
Description (DE)
CAMPTO Inf Konz 300 mg/15ml Cytosafe 15 ml
Market launch
22/10/2007
Narcotic (BTM)
No

Available generics

Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 57.25
View
Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 115.40
View
Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 283.55
View
Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 405.70
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 57.60
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 116.25
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 283.55
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 410.50
View
Irinotecan-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
CHF 57.85
View
Irinotecan-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
CHF 115.85
View

Other packaging sizes

CAMPTO conc perf 40 mg/2ml cytosafe 2 ml
1 DUR
View
CAMPTO conc perf 100 mg/5ml cytosafe 5 ml
1 DUR
View